Kim Raineri
Chief Technology OfficerMr. Kim Raineri, MBA., is Chief Technology Officer of Aspen Neuroscience, Inc. from July 2022. Mr. Raineri joined the Aspen Neuroscience, Inc. in July 2022. Mr. Raineri has served as Chief Technical Operations Officer at AVROBIO, Inc. since 2022 until July 2022 and served as its Chief Manufacturing Officer since June 2020 until July 2022 and served as its Chief Technology Officer since June 2020 until 2022. He has deep global experience in the cell and gene therapy industry, biologics and medical device spaces, with a distinguished track record of innovation and implementation of Good Manufacturing Practices (GMP). Prior to joining AVROBIO, he served as the Vice President of operations for Nikon CeLL innovation Co., Ltd, a Japanese contract development and manufacturing organization. During his tenure, he established the company as the preferred provider of custom process development and manufacturing services for cell and gene therapy products in the Japanese market. Previously, he held management positions at Lonza, serving as the business Director for cell therapy contract manufacturing operations in Singapore and prior to that as Director of operations at Lonza’s Maryland facilities. He was also previously the senior Manager of the Tissue Processing Lab at CryoLife Inc. He holds a B.S. from the University of Miami and an MBA from Kennesaw State University.
公司職務
- 公司名稱Aspen Neuroscience, Inc.股票代碼ASPE職務Chief Technology Officer
